Research suggests that it is important for clinicians to identify the risk for ILD in patients with SSc so that therapy can be initiated.
The Law of Mass action predicts that all adverse drug reactions are related to the concentration of the drug at the site of ...
Researchers have revealed how patients with metastatic breast cancer develop resistance to Enhertu treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results